These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 7113963
1. A phase I trial of aziridinylbenzoquinone (NSC 192986) in patients with previously treated acute leukemia. Van Echo DA, Schulman P, Budman DR, Ferrari A, Wiernik PH. Am J Clin Oncol; 1982 Aug; 5(4):405-10. PubMed ID: 7113963 [Abstract] [Full Text] [Related]
2. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer. Tan CT, Hancock CH, Mondora A, Hoffman NW. Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381 [Abstract] [Full Text] [Related]
10. Phase II study of aziridinylbenzoquinone in refractory lymphoma. Case DC, Hayes DM. Cancer Treat Rep; 1983 Nov; 67(11):993-6. PubMed ID: 6357437 [Abstract] [Full Text] [Related]
11. Phase I clinical evaluation of diaziquone in childhood cancer. Ettinger LJ, Siegel SE, Belasco JB, Evans AE, Ruccione KS, Jamin DC, Rohrbaugh TM, Higgins GR. Cancer Treat Rep; 1985 Mar; 69(3):323-7. PubMed ID: 3856480 [Abstract] [Full Text] [Related]
12. Phase II clinical evaluation of AZQ in colorectal cancer. Bedikian AY, Stroehlein JR, Karlin DA, Korinek J, Bodey GP. Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831 [Abstract] [Full Text] [Related]
13. Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia. Lee EJ, Van Echo DA, Egorin MJ, Nayar MS, Shulman P, Schiffer CA. Blood; 1986 Jan; 67(1):182-7. PubMed ID: 3940546 [Abstract] [Full Text] [Related]
14. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung. Fuks JZ, Aisner J, Van Echo DA, Levitt M, Ihde DC, Carney D, Wiernik PH. Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094 [Abstract] [Full Text] [Related]
15. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ). Carey RW, Comis RL, Anbar D, Kennedy BJ, Capizzi RL, Shulman P, Booth BW, Green M, Raich PC. Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498 [No Abstract] [Full Text] [Related]
16. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans. Schilsky RL, Kelley JA, Ihde DC, Howser DM, Cordes RS, Young RC. Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028 [Abstract] [Full Text] [Related]
17. Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia. Meyers PA, Tan CT, Steinherz PG, Redner A. Cancer; 1989 Dec 15; 64(12):2416-9. PubMed ID: 2479459 [Abstract] [Full Text] [Related]
18. Phase II trial of diaziquone (AZQ) in advanced malignant melanoma. Høst H, Joss R, Pinedo H, Bruntsch U, Cavalli F, Renard G, van Glabbeke M, Rozencweig M. Eur J Cancer Clin Oncol; 1983 Feb 15; 19(2):295-8. PubMed ID: 6681775 [Abstract] [Full Text] [Related]
19. A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group. Ettinger LJ, Krailo M, Ruccione KS, Krivit W, Hammond GD. Am J Pediatr Hematol Oncol; 1988 Feb 15; 10(1):18-22. PubMed ID: 3189713 [Abstract] [Full Text] [Related]
20. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial. Budman DR, Forastiere A, Perloff M, Perry M, Aisner J, Weinberg V, Wood W. Cancer Treat Rep; 1982 Oct 15; 66(10):1875-6. PubMed ID: 7127327 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]